University of Exeter Featured PhD Programmes
University of Southampton Featured PhD Programmes
Heriot-Watt University Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
Centre for Genomic Regulation (CRG) Featured PhD Programmes

Defining how reactive small molecules in cells regulate the oncogenic KRAS.G12C GTPase

Project Description

PhD Start date: September 2020

The KRAS gene are among the most mutated genes in cancer cells. KRAS.G12C (glycine at position 12 to cysteine), which is found in about 12% of all KRAS-mutated cancers, has attracted much attention as the cysteine residue is highly reactive. Being nucleophilic and redox-sensitive, it can react with electrophiles and oxidants – this reactivity is exploited to develop KRAS.G12C-selective inhibitors. However, reactions between KRAS.G12C and endogenous electrophiles have not been reported.

One of the major environmental factors that affect electrophiles in tissues and cells is smoking, which has a proven correlation with lung cancer occurrence. Interestingly, in KRAS-mutated lung cancer samples, G12C incidence is as high as over 40%.

This interdisciplinary project in the Tanaka and Hopkinson groups will assess whether KRAS.G12C reacts with cellular electrophiles/oxidants and whether these reactions affect KRAS biology. Ultimately, these studies will help to define how KRAS.G12C induces cancer and will lead to novel chemotherapies.

Academic entry requirements:
UK Bachelor Degree with at least 2:1 in a relevant subject or overseas equivalent.

How to apply:
Standard application:

UK and EU candidates only

Funding Notes

Funding Source: Funding Source

Funds will cover stipend (at Research Council rates)

University tuition fee waiver for 3 years

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully

FindAPhD. Copyright 2005-2019
All rights reserved.